#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leber's congenital amaurosis Pustular psoriasis Idiopathic intracranial hypertension White matter lesion Becker's muscular dystrophy Adrenoleukodystrophy Trigeminal neuralgia Skin cancer Ataxia telangiectasia Lymphoma Pyoderma gangrenosum Deafness bilateral Mycobacterium abscessus infection Tourette's disorder MELAS syndrome More trials…

    Learn about Rare Diseases

    Angiosarcoma recurrent – Life with Disease Synovial sarcoma metastatic – Basic Information Glomerulonephritis rapidly progressive – Life with Disease Breast angiosarcoma metastatic – Basic Information X-linked lymphoproliferative syndrome – Trials in Disease Hereditary neuropathic amyloidosis – Trials in Disease Piriformis syndrome – Diagnostics Splenic marginal zone lymphoma – Life with Disease Haemophilia B with anti factor IX – Life with Disease Haemolytic uraemic syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefotaxime Sodium Atezolizumab Cefazolin Img-007 Maraviroc Enomimeran Cabotegravir Sodium ANXV Ads-010 Rbd4059 Pralatrexate Rifampicin Nortriptyline Hydrochloride Abbv-668 Lenomorelin Imatinib Mesilate PUCOTENLIMAB Efruxifermin Sotalol Hydrochloride Inebilizumab More therapies…

    Learn about Your Condition

    Dermatomyositis Penile squamous cell carcinoma Irritable bowel syndrome Toxic epidermal necrolysis Hypertonic bladder Hyperkalaemia Acute respiratory failure Polycystic ovarian syndrome Aplastic anaemia Depression Postprandial hypoglycaemia Malignant fibrous histiocytoma Encephalopathy neonatal Psychotic behaviour Immune thrombocytopenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Long-Term Safety Study of NTLA-2002 for Patients with Hereditary Angioedema, Using Messenger RNA Encoding Cas9 and HU-G012267

    Recruiting

    1 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Lonvoguran
    • Ziclumeran
    France Germany The Netherlands

  • Study on the Safety and Effects of ION356 for Patients with Pelizaeus-Merzbacher Disease

    Recruiting

    1 1 1
    Investigated Diseases:
    • Pelizaeus-Merzbacher disease
    Investigated Drugs:
    • 2′-O-(2-Methoxyethyl) Modified Antisense Oligonucleotide Targeting Plp1 Pre-Mrna
    France Germany The Netherlands

  • Study on Gallium (68Ga) Chloride PET/CT for Detecting Lymph Node Metastasis in Patients with Early Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Gallium (68Ga) Chloride
    The Netherlands

  • Study on Anakinra for Patients with Long COVID and Ongoing Respiratory Symptoms

    Recruiting

    4 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Anakinra
    Germany Greece Italy Spain

  • Study of Anifrolumab for Children and Teens with Moderate to Severe Lupus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anifrolumab
    France Germany Italy Poland Portugal Spain

  • Study on the Safety and Effectiveness of Zipalertinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with Specific EGFR Mutations

    Recruiting

    2 1 1
    Investigated Drugs:
    • Digoxin
    • Midazolam
    • Zipalertinib
    France Germany Italy Spain
Previous Page
1 … 546 547 548 549 550 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!